Abstract

Following the immense pushback against the Drug Enforcement Administration's (DEA's) proposal to require patients prescribed buprenorphine via telemedicine to see a physician within 30 days, the agency, along with the Substance Abuse and Mental Health Services Administration (SAMHSA), has temporarily extended full telemedicine prescribing of controlled substances.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call